Citations

Clear

4207 citation(s) found for "Chen, Yu".

Vibro-acoustography of small spheres
Greenleaf, James F. , Chen, Shigao , Fatemi, Mostafa

Mayo Clinic

The Journal of the Acoustical Society of America | July 26, 2012 | Volume: 108 | Issue: 5_Supplement | Pages: 2505-2505

10.1121/1.4743254 Get It

Vibro-acoustography is a method for imaging the acoustic energy emitted from objects in response to an oscillatory radiation force produced by two interfering focused beams of ultrasound [M. Fatemi and J. F. Greenleaf, Science 280, 82–85 (1998)]. To facilitate quantitative study, a model is presented that describes the behavior of an elastic sphere in two plane ultrasound waves of slightly different frequencies. The vibrating velocity and the resulting acoustic emission of the sphere at the difference frequency are derived from the radiation force and the impedance of the sphere. For small steel spheres in water, the velocity and emission are predicted to have a simple relationship with the difference frequency and the size of the sphere. Experiments on small stainless steel spheres of different size are carried out for a number of difference frequencies, with a laser interferometer to measure the velocity of the sphere and a calibrated hydrophone to measure the acoustic emission from the sphere. The experimental results fit the model description well. This means that vibro-acoustography may be useful in quantitative measurement.
Abstract 1900: Age at last birth and endometrial cancer risk: Pooled analysis in the Epidemiology of Endometrial Cancer Consortium
Karageorgi, Stalo , Deming, Sandra L., Anderson, Kristin E. , Brinton, Louise A. , Chen, Chu , Horn‐Ross, Pamela L., Lissowska, Jolanta , Lurie, Galina, Mack, Thomas M. , Matsuno, Rayna K., McCann, Susan E. , Moysich, Kristen B., Pike, Malcolm C. , Shu, Xiao-Ou , Strom, Brian L., Group, The Australian National Endometrial Cancer Study, Ursin, Giske , Webb, Penny M., Weiss, Noel S. , Wentzensen, Nicolas , Setiawan, Veronica Wendy , Bernstein, Leslie , Cai, Hui , Cerhan, James R. , Cozen, Wendy , Doherty, Jennifer A. , Freudenheim, Jo L. , Goodman, Marc T. , Rebbeck, Timothy R. , Robien, Kim , Shu, Xiao-Ou , Spurdle, Amanda B. , Group, The Australian National Endometrial Cancer Study, Xiang, Yong‐Bing , Webb, Penny M., Yang, Hannah , Vivo, Immaculata De , Lissowska, Jolanta

Mayo Clinic

Cancer Research | July 21, 2012 | Volume: 71 | Issue: 8_Supplement | Pages: 1900-1900

10.1158/1538-7445.am2011-1900 Get It

Abstract Some studies show that childbearing at older age is associated with lower risk of endometrial cancer, but whether the association is independent of number of children or other factors still requires clarification. We pooled individual-level data from epidemiologic studies in the Epidemiology of Endometrial Cancer Consortium (E2C2). Data on age at last birth and/or last pregnancy were available from 14 studies: 11 case-control studies and 3 cohort studies; the latter were analyzed using a nested case-control design. A total of 9,613 endometrial cancer cases and 17,112 controls were included in the analysis. The majority of women were White (82%) and older than 55 years (69%). We estimated the effects of age at last birth using data from 12 studies and age at last pregnancy using data from 10 studies on the risk of endometrial cancer by calculating odds ratios (OR) and 95% confidence intervals (95% CI) using logistic regression models. Potential confounders included in the analysis were race, body mass index, parity, age at menarche, age at first birth, oral contraceptive use, postmenopausal hormone use, smoking status, and report of diabetes. After adjusting for potential confounders, a reduction in endometrial cancer risk was observed in women with increasing age at last birth (P trend <0.0001) and age at last pregnancy (P trend <0.0001). The OR per five-year increase in age at last birth and age at last pregnancy was 0.90 (95%CI: 0.86, 0.94) and 0.91 (95% CI: 0.87, 0.95), respectively. Women who had their last child at an age >40 years were at a 34% decreased risk compared with women who had their last child at an age <25 years (95% CI: 0.52, 0.82). Compared to women with age at last pregnancy <25 years, those with age at last pregnancy >40 years had a 30% decreased risk of endometrial cancer (95%CI: 0.57, 0.86). Inverse associations were observed for Whites and Asians in race-specific analysis and also in analysis restricted to women with at least 2 births. In this large pooled analysis, we show that late age at last birth or last pregnancy is a strong and independent protective factor for endometrial cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1900. doi:10.1158/1538-7445.AM2011-1900
O2‐06‐04: Impact of different PET image quantification methods, regions‐of‐interest and risk factors on the power to detect a slowing in beta‐amyloid deposition in presymptomatic Alzheimer's disease trials
Fleisher, Adam , Roontiva, Auttawut, Lee, Wendy , Esque, Jacquelin, Bandy, Dan, Caselli, Richard J., Reiman, Eric M. , Liu, Xiaofen , Chen, Kewei , Thiyyagura, Pradeep

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2012.05.657 Get It

The Decline in Pulsatile GH Secretion throughout Early Adulthood in Mice Is Exacerbated by Dietary-Induced Weight Gain
Huang, Lili , Steyn, Frederik J. , Tan, H. Y. , Xie, T. Y. , Veldhuis, Johannes D. , Ngo, Shyuan T. , Chen, Chen , Steyn, F J , Chen, C

Mayo Clinic

Endocrinology | July 17, 2012 | Volume: 153 | Issue: 9 | Pages: 4380-4388

10.1210/en.2012-1178 | PMID 22802464 Get It

The transition between puberty and adulthood is accompanied by a slowing in linear growth. Although GH is a key factor that drives somatic development into adulthood, early adulthood coincides with a reduction in circulating levels of GH. To this extent, a pathological decline in postpubertal GH secretion is detrimental to attainment of peak lean muscle mass and bone mass and promotes adiposity and increases susceptibility to the development of obesity in adulthood. Here we characterized pulsatile GH secretion in C57BL/6J mice at 12 and 16 wk of age. Deconvolution analysis of these measures reveals a reduction in pulsatile GH secretion between 12 and 16 wk of age. Dietary intervention with high-fat feeding at 8 wk of age results in a significant increase in adiposity, the development of glucose intolerance, and hyperinsulinemia. We show the exacerbation of the age-associated decline in pulsatile GH secretion in high-fat-fed mice after 4 wk of dietary intervention (at 12 wk of age), and a further suppression of pulsatile GH secretion by 8 wk of dietary intervention (at 16 wk of age). Suppressed pulsatile secretion of GH did not coincide with an elevation in circulating free fatty acids. Rather, we observed increased hepatic triglyceride content and an eventual decrease in circulating levels of IGF-I. Given the established role of GH in maintaining healthy aging, we anticipate that an advancing of the age-associated decline in pulsatile GH secretion as a consequence of dietary-induced weight gain may have long-term ramifications on adult health.
A Phase I Trial and Pharmacokinetic Study of Aflibercept (VEGF Trap) in Children with Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report
Bender, Julia Glade , Blaney, Susan M. , Baruchel, Sylvain , Ahern, Charlotte H., Ingle, Ashish M., Chen, Alice P. , Weigel, Brenda J. , Adamson, Peter C. , Borinstein, Scott C. , Reid, Joel M. , Yamashiro, Darrell J. , Park, Julie R. , Glade-Bender, Julia

Mayo Clinic

Clinical Cancer Research | July 13, 2012 | Volume: 18 | Issue: 18 | Pages: 5081-5089

10.1158/1078-0432.ccr-12-0078 | PMID 22791883 Get It

Abstract Purpose: Aflibercept is a novel decoy receptor that efficiently neutralizes circulating VEGF. A pediatric phase I trial was conducted to define the dose-limiting toxicities (DLT), maximum tolerated dose (MTD), and pharmacokinetics (PK) of aflibercept. Experimental Design: Cohorts of three to six children with refractory solid tumors received aflibercept intravenously over 60 minutes every 14 days, at 2.0, 2.5, or 3.0 mg/kg/dose. PK sampling and analysis of peripheral blood biomarkers were conducted with the initial dose. Results: Twenty-one eligible patients were enrolled; 18 were fully evaluable for toxicity. One of six patients receiving 2.0 mg/kg/dose developed dose-limiting intratumoral hemorrhage and two of six receiving 3.0 mg/kg/dose developed either dose-limiting tumor pain or tissue necrosis. None of the six patients receiving 2.5 mg/kg/dose developed DLTs, defining this as the MTD. The most common non-DLTs were hypertension and fatigue. Three patients with hepatocellular carcinoma, hepatoblastoma and clear cell sarcoma had stable disease for >13 weeks. At the MTD, the ratio of free-to-bound aflibercept serum concentration was 2.10 on day 8 but only 0.44 by day 15. A rapid decrease in VEGF (P < 0.05) and increase in placental growth factor (PlGF; P < 0.05) from baseline was observed in response to aflibercept by day 2. Conclusions: The aflibercept MTD in children of 2.5 mg/kg/dose every 14 days is lower than the adult recommended dose of 4.0 mg/kg. This dose achieves, but does not sustain, free aflibercept concentrations in excess of bound. Tumor pain and hemorrhage may be evidence of antitumor activity but were dose-limiting. Clin Cancer Res; 18(18); 5081–9. ©2012 AACR.
CD8 T Cell-Initiated Blood–Brain Barrier Disruption Is Independent of Neutrophil Support
Johnson, Holly L. , Jin, Fang, Hanson, Lisa , Gamez, Jeffrey D., Pirko, Istvan, Johnson, Aaron J. , Chen, Yi , Johnson, Aaron J.

Mayo Clinic

The Journal of Immunology | July 7, 2012 | Volume: 189 | Issue: 4 | Pages: 1937-1945

10.4049/jimmunol.1200658 | PMID 22772449 Get It

Abstract Blood–brain barrier (BBB) disruption is a common feature of numerous neurologic disorders. A fundamental question in these diseases is the extent inflammatory immune cells contribute to CNS vascular permeability. We have previously shown that CD8 T cells play a critical role in initiating BBB disruption in the peptide-induced fatal syndrome model developed by our laboratory. However, myelomonocytic cells such as neutrophils have also been implicated in promoting CNS vascular permeability and functional deficit in murine models of neuroinflammatory disease. For this reason, we evaluated neutrophil depletion in a murine model of CD8 T cell-initiated BBB disruption by employing traditionally used anti-granulocyte receptor-1 mAb RB6-8C5 and Ly-6G–specific mAb 1A8. We report that CNS-infiltrating antiviral CD8 T cells express high levels of granulocyte receptor-1 protein and are depleted by treatment with RB6-8C5. Mice treated with RB6-8C5, but not 1A8, display: 1) intact BBB tight junction proteins; 2) reduced CNS vascular permeability visible by gadolinium-enhanced T1-weighted magnetic resonance imaging; and 3) preservation of motor function. These studies demonstrate that traditional methods of neutrophil depletion with RB6-8C5 are broadly immune ablating. Our data also provide evidence that CD8 T cells initiate disruption of BBB tight junction proteins and CNS vascular permeability in the absence of neutrophil support.
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease
Cooper, Oliver , Seo, Hyemyung , Andrabi, Shaida A. , Guardia‐Laguarta, Cristina , Graziotto, John J. , Sundberg, Maria , McLean, Jesse R., Carrillo‐Reid, Luis , Xie, Zhong , Osborn, Teresia, Hargus, Gunnar , Deleidi, Michela , Lawson, Tristan, Bogetofte, Helle , Pérez-Torres, Eduardo , Clark, Lorraine N. , Moskowitz, Carol, Mazzulli, Joseph R. , Chen, Li , Romero, Norma B. , Jiang, Houbo , Uitti, Ryan J. , Huang, Zhigao, Opala, Grzegorz, Scarffe, Leslie A. , Dawson, Valina L. , Klein, Christine , Ross, Owen A. , Trojanowski, John Q. , Marder, Karen, Przedborski, Serge , Krainc, Dimitri , Dawson, Ted M. , Isacson, Ole , Volpicelli‐Daley, Laura A. , Feng, Jian , Lee, Virginia M.‐Y. , Surmeier, Dalton James , Wszołek, Zbigniew K. , Ross, Owen A , Klein, Christine , Dawson, Valina L , Deleidi, Michela

Mayo Clinic

Science Translational Medicine | July 4, 2012 | Volume: 4 | Issue: 141 | Pages: No page available

10.1126/scitranslmed.3003985 | PMID 22764206 Get It

Neural cells derived from induced pluripotent stem cells from patients with genetic forms of Parkinson’s disease provide insights into disease pathogenesis.
Abstract 2738: Insights into survival from ovarian cancer revealed by gene set analysis
Jenkins, Gregory D. , Fenstermacher, David, Schildkraut, Joellen M. , Sutphen, Rebecca , Chen, Y. Ann, Iversen, Edwin S., Cunningham, Julie M. , Chen, Zhihua , Sellers, Thomas A. , Goode, Ellen L. , Fridley, Brooke L. , Tsai, Ya-Yu , Vierkant, Robert A.

Mayo Clinic

Cancer Research | June 27, 2012 | Volume: 71 | Issue: 8_Supplement | Pages: 2738-2738

10.1158/1538-7445.am2011-2738 Get It

Abstract Epithelial ovarian cancer (EOC) is the 6th most commonly diagnosed cancer among women in the world, accounting for 4% of all female cancers. On a worldwide basis, an estimated 204,000 new cases are diagnosed and 125,000 women die of EOC annually, with 5-year survival rate at 45%. Metastasis and its complications are the usual cause of EOC-related deaths. Thus, factors related to tumor aggressiveness, response to therapy, and the underlying health state of the patient often predict survival. Candidate gene and genome-wide association studies (GWAS) for survival from EOC have discovered only a few the genetic variants, accounting for only a small proportion of the heritability. One explanation for the missing heritability is that the common analysis approach _ assessing the effect of each single nucleotide polymorphism (SNP) individually _ is not well suited to the detection of small effects of multiple SNPs. Gene set analysis (GSA) overcomes this limitation by assessing the overall evidence of association of a phenotype with all measured variation in a set of genes or pathway. Therefore, we conducted a GSA using data from an EOC GWAS, using the Illumina 610-quad SNP array, to determine novel gene sets (GSs) associated with overall survival (OS) from EOC (N cases = 1057, N deaths = 495). All subjects were non-Hispanic, non-Jewish Caucasians, with sample and SNP call rates >95%. Subjects with ambiguous gender, unresolved identical genotypes, and less than 80% European ancestry were also excluded. SNPs were mapped to genes within 20 kb, with genes then mapped to GSs defined by the following: KEGG, Gene Ontology (biological, cellular, molecular) and PharmGKB. GSA was completed in which the association of each gene with OS was assessed using a principal component gene-level test (adjusting for study site, age and population sub-structure based on the first eigenvector from EigenStrat), followed by the aggregation of the gene-level p-values using the Gamma method with a soft truncation threshold of 0.15. Empirical p-values were determined using permutation methods. Of the 2,573 GSs assessed, 30 GSs had a p-value < 0.01. The top GSs were related to: mismatch repair (p = 3.0E-4), platelet formation (p=0.001), leukocyte adhesive activation (p=0.002), antigen processing and presentation of endogenous antigens (p = 0.002) or peptide antigens (p = 0.002), platinum pathway (p = 0.003), aging and lifespan (p = 0.004, p = 0.007), immune system development (p = 0.004) and somatic diversification (p=0.007). These results illustrate the usefulness of GSA for the development of novel hypotheses that can be followed-up with additional clinical or functional studies. Moreover, application of GSA to survival from EOC allowed the detection of significant GSs (and the corresponding genes/SNPs within these GSs) that impact OS that were not detected by assessing each SNP individually, where the smallest p-value from single SNP analysis of the GWAS for OS was 1.3E-05. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2738. doi:10.1158/1538-7445.AM2011-2738
Abstract 4729: Pathway and gene set analyses for epithelial ovarian cancer (EOC) genome-wide association study (GWAS)
Chen, Zhihua , Qu, Xiaotao , Iversen, Edwin S., Permuth‐Wey, Jenny, Cunningham, Julie M. , Fenstermacher, David, Sutphen, Rebecca , Phelan, Catherine M., Birrer, Michael J. , Narod, Steven A. , Schildkraut, Joellen M. , Goode, Ellen L. , Sellers, Thomas A. , Chen, Y. Ann , Tsai, Ya-Yu , Barnholtz‐Sloan, Jill S. , Fridley, Brooke L. , Risch, Harvey A. , Vierkant, Robert A. , Monteiro, Álvaro N.A. , Cramer, Daniel W. , McLaughlin, John

Mayo Clinic

Cancer Research | June 27, 2012 | Volume: 71 | Issue: 8_Supplement | Pages: 4729-4729

10.1158/1538-7445.am2011-4729 Get It

Abstract The etiology of ovarian cancer is poorly understood but there is clearly a heritable component. Efforts to identify susceptibility alleles rarely consider interactions among alleles or their joint effects because it quickly becomes computationally intractable. In this study, we sought to identify multi-SNP effects jointly with a pathway-based analysis (GSEA-SNP) of 1,952 EOC cases and 2,042 frequency-matched controls genotyped with the Illumina 610K array. All subjects were self-reported non-Hispanic non-Jewish Caucasians, with SNP and sample call rates > 95%. Subjects with ambiguous gender, unresolved identical genotypes and < 80% European ancestry were excluded. SNPs with MAF < 1% were excluded. Missing genotypes were inferred using Mach based on the HapMap CEU population. SNPs not within introns were annotated to genes within 100 bp. We retrieved the following databases of gene sets (GSs) from a compiled database, MsigDB: human chromosome and cytogenetic band, chemical and genetic perturbations, canonical pathways, microRNA binding targets, transcription factor targets (TFT), cancer gene neighborhood (CGN), Cancer modules and Gene Ontology. The GSEA-SNP approach calculates and rank orders the trend statistic for association between each SNP and EOC risk. The Enrichment Score (ES) estimates the overrepresentation of top-ranked SNPs for each GS; the statistical significance was estimated using 10,000 permutations. The ES was normalized according to the size of GS to yield Normalized Enrichment Score (NES). The false discovery (FDR) rate was estimated using NES to adjust for multiple hypothesis testing. A total of 5181 gene-sets were included in the analysis. When controlling the FDR at 15%, 14 of the GSs were highly enriched with association signals, including two chromosomal regions, 8q13 (p = 0.0055, FDR = 0.15) and 6p24 (p = 0.0012, FDR = 0.08). BIOCARTA_LYM_PATHWAY, a pathway related to cell adhesion and diapedesis of lymphocytes, was also significant (p = 0.0002, FDR = 0.12). A TFT GS, composed of genes with promoter regions around transcription start sites containing the motif GGCNRNWCTTYS, was associated with risk (p = 0.0004, FDR = 0.08). Currently, no known transcription factors bind to this computationally predicted motif. Molecular function of double stranded RNA binding was also enriched (p = 0.005, FDR = 0.10). The remaining enriched sets were CGN sets, for which the neighborhoods around the cancer genes were originally defined using correlation of gene expression from 4 large data sets of various cancer types. The enriched CGN included: CD48 (p = 0.011), CD53 (p = 0.009), CD97 (p = 0.011), INPP5D (p = 0.010), PTPN6 (p = 0.008), VAV1 (p = 0.011), ITGAL (p = 0.012), PTPRC (p = 0.012), and STAT6 (p = 0.010). In summary, these analyses detected biologically plausible GSs related to etiology of EOC, highlighting SNPs in core enrichment groups that were not identified using individual SNP tests. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 4729. doi:10.1158/1538-7445.AM2011-4729
Abstract 4704: A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis
Bi, Xiuli , Pohl, Nicole M., Cheng, Yulan , Zhou, Yixing , Wang, Shaomeng , Xu, Xiaochun , Hong, Jun‐Yan, Xie, Heng , Wei, Qingyi , Meltzer, Stephen J. , Ding, Ivan , Okunieff, Paul, Wang, Lidong , Shears, Stephen B. , Huang, Peng , Chen, Zhong , Wang, Liang , Yang, Wancai , Wang, Shaomeng , Meltzer, Stephen J

Mayo Clinic

Cancer Research | June 27, 2012 | Volume: 71 | Issue: 8_Supplement | Pages: 4704-4704

10.1158/1538-7445.am2011-4704 Get It

Abstract Phospholipase C epsilon (PLCε or PLC∈ 1) is a phosphoinositide-specific enzyme phospholipase C that converts phosphatidylinositol 4,5-biphosphate to two intracellular second messengers, diacylglycerol and inositol 1,4,5-trisphosphate, which regulate protein kinase C activity and calcium mobilization, respectively. These responses are involved in the regulation of cell growth, differentiation and oncogenesis. However, the involvement of PLCε in human carcinogenesis, particularly in esophageal cancer, was not been recognized until a susceptible SNP (rs2274223: A5780G:His1927Arg) was recently identified in a large genome-wide association study (GWAS). This SNP, located within exon 26 and C2 domain of the PLCε gene at chromosome 10q23, leads to a nonsynonymous alteration from CAC (A allele, encoding histidine) to CGC (G allele, encoding arginine), which was associated with an increased risk of both squamous cell carcinoma and esophagus-cardia gastric adenocarcinoma. In the current report, we demonstrate that the presence of the G allele (AG or GG) at this locus leads to increased PLCε mRNA and protein expression in human esophageal cancer tissues and in human esophageal cancer cell lines. The present of G allele also leads o a higher enzyme activity in esophageal cancer cells in vitro. Quantitative analysis of the C2 domain sequences revealed that A:G allelic imbalance is strongly associated with esophageal malignancy. Moreover, the analysis of 10,614 non-cancer subjects from high- and low-risk areas of China demonstrated that the presence of the G allele is strongly associated with moderate to severe esophagitis in the subjects from the high-risk areas of China: 77% of the severe esophagitis individuals in high-risk areas had AG/GG genotypes vs. only 37% of these subjects in low-risk areas (OR 6.03 with 95% CI 1.59-22.9 vs. OR 0.74 with 95% CI 0.33-1.64; p=0.008). These data suggest that the interaction of potential environmental factors with PLCε, particularly in individuals with AG or GG allele, not only exists in high-risk areas for esophageal cancer development in China, but also correlates with the severity of esophagitis. In conclusion, PLCε is likely to play a pivotal role in esophageal carcinogenesis: the presence of the 5780G allele may not only predict a high risk of future esophageal cancer development, but may also participate in esophageal cancer growth and progression by upregulating levels of PLCε mRNA, protein, and enzyme activity, ultimately leading to augmentation of the inflammatory process in esophageal epithelium. Thus, the 5780G allele in PLCε may constitute a promising biomarker for esophageal squamous carcinoma risk stratification, early detection, and progression prediction. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 4704. doi:10.1158/1538-7445.AM2011-4704